These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 18360284)

  • 1. Ependymomas of the central nervous system and adult extra-axial ependymomas are morphologically and immunohistochemically distinct--a comparative study with assessment of ovarian carcinomas for expression of glial fibrillary acidic protein.
    Idowu MO; Rosenblum MK; Wei XJ; Edgar MA; Soslow RA
    Am J Surg Pathol; 2008 May; 32(5):710-8. PubMed ID: 18360284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ovarian ependymomas of extra-axial type or central immunophenotypes.
    Stolnicu S; Furtado A; Sanches A; Nicolae A; Preda O; Hincu M; Nogales FF
    Hum Pathol; 2011 Mar; 42(3):403-8. PubMed ID: 21195452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis of alternative and traditional immunohistochemical markers for the distinction of ovarian sertoli cell tumor from endometrioid tumors and carcinoid tumor: A study of 160 cases.
    Zhao C; Bratthauer GL; Barner R; Vang R
    Am J Surg Pathol; 2007 Feb; 31(2):255-66. PubMed ID: 17255771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histological spectrum of ependymomas and correlation of p53 and Ki-67 expression with ependymoma grade and subtype.
    Suri VS; Tatke M; Singh D; Sharma A
    Indian J Cancer; 2004; 41(2):66-71. PubMed ID: 15318011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. March 2003: a 41 -year-old female with a solitary lesion in the liver.
    Wiendl H; Feiden W; Scherieble H; Renz T; Dichgans J; Weller M
    Brain Pathol; 2003 Jul; 13(3):421-3. PubMed ID: 12946033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ependymoma of the ovary. A case report with immunohistochemical, ultrastructural, and DNA cytometric findings, as well as histogenetic considerations.
    Guerrieri C; Jarlsfelt I
    Am J Surg Pathol; 1993 Jun; 17(6):623-32. PubMed ID: 8333561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphous low-grade adenocarcinoma versus pleomorphic adenoma of minor salivary glands: resolution of a diagnostic dilemma by immunohistochemical analysis with glial fibrillary acidic protein.
    Curran AE; White DK; Damm DD; Murrah VA
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Feb; 91(2):194-9. PubMed ID: 11174597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: from the 'MALOVA' ovarian cancer study.
    Høgdall EV; Christensen L; Høgdall CK; Blaakaer J; Gayther S; Jacobs IJ; Christensen IJ; Kjaer SK
    Oncol Rep; 2007 Nov; 18(5):1051-9. PubMed ID: 17914554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian mature teratomas with mucinous epithelial neoplasms: morphologic heterogeneity and association with pseudomyxoma peritonei.
    McKenney JK; Soslow RA; Longacre TA
    Am J Surg Pathol; 2008 May; 32(5):645-55. PubMed ID: 18344868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular markers of primitive neuroectodermal tumors and other pediatric central nervous system tumors. Monoclonal antibodies to neuronal and glial antigens distinguish subsets of primitive neuroectodermal tumors.
    Molenaar WM; Jansson DS; Gould VE; Rorke LB; Franke WW; Lee VM; Packer RJ; Trojanowski JQ
    Lab Invest; 1989 Dec; 61(6):635-43. PubMed ID: 2557487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitivity and specificity of epithelial membrane antigen staining patterns in ependymomas.
    Hasselblatt M; Paulus W
    Acta Neuropathol; 2003 Oct; 106(4):385-8. PubMed ID: 12898159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ependymomas with neuronal differentiation: a morphologic and immunohistochemical spectrum.
    Rodriguez FJ; Scheithauer BW; Robbins PD; Burger PC; Hessler RB; Perry A; Abell-Aleff PC; Mierau GW
    Acta Neuropathol; 2007 Mar; 113(3):313-24. PubMed ID: 17061076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OLIG2 is a useful immunohistochemical marker in differential diagnosis of clear cell primary CNS neoplasms.
    Preusser M; Budka H; Rössler K; Hainfellner JA
    Histopathology; 2007 Feb; 50(3):365-70. PubMed ID: 17257132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovarian nonsmall cell neuroendocrine carcinoma: a clinicopathologic and immunohistochemical study of 11 cases.
    Veras E; Deavers MT; Silva EG; Malpica A
    Am J Surg Pathol; 2007 May; 31(5):774-82. PubMed ID: 17460463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An immunohistochemical and morphological analysis of post-chemotherapy ovarian carcinoma.
    Miller K; Price JH; Dobbs SP; McClelland RH; Kennedy K; McCluggage WG
    J Clin Pathol; 2008 May; 61(5):652-7. PubMed ID: 18006668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The utility of calretinin, inhibin, and WT1 immunohistochemical staining in the differential diagnosis of ovarian tumors.
    Cathro HP; Stoler MH
    Hum Pathol; 2005 Feb; 36(2):195-201. PubMed ID: 15754297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian ependymoma. A case report.
    Garcia-Barriola V; De Gómez MN; Suárez JA; Lara C; González JE; García-Tamayo J
    Pathol Res Pract; 2000; 196(8):595-9. PubMed ID: 10982025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphologic spectrum of immunohistochemically characterized clear cell carcinoma of the ovary: a study of 155 cases.
    DeLair D; Oliva E; Köbel M; Macias A; Gilks CB; Soslow RA
    Am J Surg Pathol; 2011 Jan; 35(1):36-44. PubMed ID: 21164285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic oophorectomy: a morphologic and immunohistochemical study.
    Schlosshauer PW; Cohen CJ; Penault-Llorca F; Miranda CR; Bignon YJ; Dauplat J; Deligdisch L
    Cancer; 2003 Dec; 98(12):2599-606. PubMed ID: 14669279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WT1, estrogen receptor, and progesterone receptor as markers for breast or ovarian primary sites in metastatic adenocarcinoma to body fluids.
    Lee BH; Hecht JL; Pinkus JL; Pinkus GS
    Am J Clin Pathol; 2002 May; 117(5):745-50. PubMed ID: 12090423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.